Login / Signup

Efficacy and safety of Helicobacter pylori eradication therapy immediately after endoscopic submucosal dissection.

Yoshiaki TakahashiToshihisa TakeuchiYuichi KojimaYasuaki NagamiMasaki OminamiNoriya UedoKenta HamadaHaruhisa SuzukiIchiro OdaYouichi MiyaokaSatoshi YamanouchiSatoshi TokiokaNaoya TomatsuriNorimasa YoshidaYuji NaitoTakashi NonakaShinya KodashimaShinichi OgataYasushi HongoTadayuki OshimaZhaoliang LiKotaro ShibagakiTomoyuki OikawaKazunari TominagaKazuhide Higuchi
Published in: Journal of gastroenterology and hepatology (2018)
This study failed to demonstrate the non-inferiority of immediate H. pylori eradication therapy after ESD to the non-eradication therapy in the healing rate of ESD-caused ulcers. However, because the failure is likely to attribute to small number of patients enrolled, immediate eradication therapy may be a treatment option for patients after ESD without adverse effects on eradication therapy in comparison with the standard therapy.
Keyphrases
  • helicobacter pylori
  • helicobacter pylori infection
  • ejection fraction
  • endoscopic submucosal dissection
  • end stage renal disease
  • newly diagnosed
  • stem cells
  • prognostic factors
  • bone marrow
  • patient reported outcomes